However, evidence implicates adiponectin in β-cell adaptation and survival in pregnancy, as well as glucose homeostasis, so other strategies to increase circulating adiponectin or downstream adiponectin signalling safely in pregnancy could be effective therapies for GDM. Here, ADIPOQ is linked to gestational diabetes.